Harnessing AI in Life Sciences: Using Technology as an Enabler Across the Clinical Development – Post-Marketing Continuum

Artificial intelligence (AI) is poised to have a transformative impact across the entire drug development continuum from preclinical research to post-marketing support.

When implemented appropriately, AI-driven technologies, from natural language processing and predictive analytics to machine learning algorithms, can streamline workflows, enhance signal detection and improve risk management. The key to effectively harnessing AI in life sciences is understanding the obstacles to be overcome and how technology can be used to mitigate those challenges.

Pharmacovigilance (PV) is an area of drug development that is prime for AI transformation. Confronted with an increasing volume and velocity of data that must be sourced from diverse channels, case processors are challenged to maintain accuracy, speed and regulatory compliance. Leveraging AI as an enabler to optimize the aspects of PV that are onerous streamlines intake and tracking, reserving human resources for the work that requires human intervention.

This webinar will explore the effective use of AI across the clinical development–post-marketing continuum, with a focus on how process automation and tech-enabled innovation is reshaping the landscape of PV. The key topics will include:

• Current trends in AI for drug development
• Challenges of PV
• AI solutions for streamlining post-market safety monitoring
• Future opportunities for AI in the clinical development–post-marketing continuum

Register for this webinar to stay ahead of AI advancements in life sciences and learn how to integrate innovative solutions into drug development strategies.

Speaker

Nancy Maher, Chief Technology Officer, PrimeVigilance

Nancy Maher serves as Ergomed’s Chief Technology Officer, bringing over 25 years of experience as a global IT leader. Known for her strategic expertise in digital transformation, technology optimization and cross-functional leadership, Nancy is poised to drive Ergomed’s continued innovation and growth.

Formerly the Senior Vice President and Chief Information Officer at Kyowa Kirin Inc., Nancy has successfully led complex IT infrastructures and global technology initiatives across pharmaceuticals, healthcare and life sciences.

Recognized internationally in the pharmaceutical, biotech and medical device industries, Nancy has a strong focus on mergers and acquisitions and has guided digital transformations across North America, Europe, LATAM and Asia. Her approach to optimizing resources and connecting global business capabilities will generate significant efficiencies while advancing Ergomed’s technology-driven services.

In her role as CTO, Nancy oversees Ergomed’s global IT team, ensuring the organization’s platforms, technology and innovation meet the highest standards of quality, security and resilience as they drive Ergomed’s vision for growth and unparalleled service. Based in New Jersey, Nancy’s leadership further strengthens Ergomed’s commitment to leveraging cutting-edge technology in delivering exceptional service and operational excellence for clients and patients worldwide.

Message Presenter